首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1821697

2025年產前DNA定序全球市場報告

Prenatal DNA Sequencing Global Market Report 2025

出版日期: 2025年09月10日 | 出版商:

The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年產前DNA定序市場將快速成長，到2029年將達到52.3億美元，年複合成長率（CAGR）為16.6%。預測期內的成長動力包括消費者對早期檢測的需求、產婦年齡成長和懷孕風險的增加、公共衛生舉措、監管支持和指南以及數據分析的進步。預測期內的主要趨勢包括研發舉措、倫理和監管考慮、數據解讀工具的改進、精準醫療的整合以及產前遺傳諮詢。

未來五年16.6%的成長率預測比我們先前的預測略有下降，下降了0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能導致德國和中國開發的高通量定序系統和生物資訊軟體價格上漲，阻礙美國全基因組胎兒定序的普及，導致交付時間延長和遺傳諮詢成本上升。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，貿易摩擦的影響可能更為廣泛。

癌症發生率的預期上升將推動產前DNA定序市場的成長。癌症的特徵是細胞不受控制地生長和擴散，這促使人們使用產前DNA定序來檢測胎兒非整倍體並識別胎兒癌症。這種定序方法可以揭示影響個體癌症易感性的遺傳或生殖系DNA變化。例如，根據美國癌症協會2023年1月的數據，預計癌症病例數將從2021年的1,898,160例增加3.16%，到2023年將達到1,958,310例。因此，癌症疫情正在推動產前DNA定序市場的發展。

全球產前DNA定序：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
最終用途產業分析
全球產前DNA定序市場：成長率分析
全球產前DNA定序市場表現：規模與成長，2019-2024年
全球產前DNA定序市場預測：規模與成長，2024-2029年，2034年
全球產前 DNA 定序：總潛在市場（TAM）

第6章市場細分

全球產前DNA定序市場：依類型、績效及預測，2019-2024年、2024-2029年、2034年
遺傳性疾病
非遺傳性疾病
全球產前DNA定序市場：應用、績效及預測（2019-2024年、2024-2029年及2034年）
血友病
唐氏症
囊腫纖維化
自閉症
Dijorglus症候群
愛滋病（愛滋病）
癌症
其他用途
全球產前 DNA 定序市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
學術研究
臨床研究
醫院和診所
製藥和生物技術公司
其他最終用戶
全球產前 DNA 定序市場：依遺傳疾病類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
單基因疾病
染色體異常
全球產前 DNA 定序市場：依非遺傳疾病（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
感染疾病
母親的健康狀況

第7章區域和國家分析

全球產前DNA定序市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
全球產前DNA定序市場：依國家、績效及預測，2019-2024年、2024-2029年、2034年

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章：澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章：加拿大市場

第26章南美洲市場

第27章：巴西市場

第28章中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

產前DNA定序市場：競爭格局
產前DNA定序市場：公司簡介
- Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- BGI Group Overview, Products and Services, Strategy and Financial Analysis
- F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

Natera Inc.
Myriad Genetics Inc.
Invitae Corporation
PerkinElmer Inc.
Macrogen Inc.
Pacific Biosciences of California Inc.
Genewiz LLC
10x Genomics Inc.
Oxford Nanopore Technologies Limited
Thermo Fisher Scientific Inc.
Berry Genomics Co. Ltd.
Centrillion Technology Holdings Corp.
Cynvenio Biosystems Inc.
Eurofins LifeCodexx AG
GeneDx Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

2029年產前DNA定序市場：哪些國家將提供新機會
2029年產前DNA定序市場：細分領域帶來新機會
2029年產前DNA定序市場：成長策略
- 基於市場趨勢的策略
- 競爭對手策略

第36章附錄

簡介目錄

Product Code: r23667u

Prenatal DNA sequencing is a method employed to sequence the DNA of an unborn baby, utilizing a blood sample from the mother to unveil the complete genetic code of the fetus. This technique is instrumental in detecting fetal disorders or diseases.

The primary types of prenatal DNA sequencing encompass genetic diseases and nonhereditary diseases. Genetic diseases refer to disorders or diseases caused by mutations in one or more genes. DNA sequencing plays a crucial role in determining whether a gene carries a mutation leading to a specific disorder. Applications of prenatal DNA sequencing include conditions such as hemophilia, Down syndrome, cystic fibrosis, autism, DiGeorge syndrome, AIDS, cancer, and others. Various users, including academic research, clinical research, hospitals and clinics, as well as pharmaceutical and biotechnology companies, employ this technology.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The prenatal DNA sequencing market research report is one of a series of new reports from The Business Research Company that provides prenatal DNA sequencing market statistics, including the prenatal DNA sequencing industry global market size, regional shares, competitors with a prenatal DNA sequencing market share, detailed prenatal DNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal DNA sequencing industry. This prenatal DNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal dna sequencing market size has grown rapidly in recent years. It will grow from $2.5 billion in 2024 to $2.82 billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to changing patient preferences, medical advancements and research, non-invasive testing adoption, rising maternal age, improved accuracy and reliability.

The prenatal dna sequencing market size is expected to see rapid growth in the next few years. It will grow to $5.23 billion in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to consumer demand for early detection, rising maternal age and pregnancy risks, public health initiatives, regulatory support and guidelines, advancements in data analysis. Major trends in the forecast period include research and development efforts, ethical and regulatory considerations, improved data interpretation tools, precision medicine integration, prenatal genetic counseling.

The forecast of 16.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of whole-genome fetal sequencing by inflating prices of high-throughput sequencing systems and bioinformatics software developed in Germany and China, resulting in slower turnaround times and higher genetic counseling costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in cancer prevalence is set to drive the growth of the prenatal DNA sequencing market. Cancer, characterized by uncontrolled cell growth and spread, prompts the use of prenatal DNA sequencing to detect fetal aneuploidy and identify cancer in the fetus. This sequencing method unveils inherited or germline DNA changes influencing a person's cancer susceptibility. For example, data from the American Cancer Society in January 2023 showed an increase in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth rate of 3.16%. Consequently, the prevalence of cancer acts as a driving force for the prenatal DNA sequencing market.

The increasing birth rate is anticipated to drive the growth of the prenatal DNA sequencing market in the coming years. The birth rate refers to the number of live births per 1,000 individuals in a specific population over a defined period, typically reported annually. Prenatal DNA sequencing is instrumental in detecting genetic abnormalities in unborn fetuses, facilitating informed reproductive choices during childbirth through selective interventions. For example, in January 2023, a report from the Centers for Disease Control and Prevention, a U.S.-based national public health organization, indicated that the United States experienced a 1% rise in registered births, amounting to 3,664,292, compared to the previous year. Consequently, the increasing birth rate is propelling the prenatal DNA sequencing market.

Product innovation is a prominent trend in the prenatal DNA sequencing market, with major companies concentrating on developing innovative solutions to enhance their market standing. Juno Diagnostics, Inc., a U.S.-based health technology company, introduced the noninvasive prenatal screening test 'Hazel' in November 2022. Designed with no risk of miscarriage, the test can be performed as early as 9 weeks into pregnancy using a small blood sample. It screens for common genetic conditions such as Down syndrome, Edwards syndrome, and Patau syndrome.

Major companies in the prenatal DNA sequencing market are pursuing a strategic partnership approach to improve technology integration and broaden their market presence. A strategic partnership generally involves a collaborative relationship among two or more organizations that combine their resources, expertise, and efforts to achieve shared goals or objectives. For example, in December 2023, BillionToOne, a U.S.-based precision diagnostics company, teamed up with a Johnson & Johnson subsidiary, a U.S.-based pharmaceutical firm, for the AZALEA Phase 3 clinical trial of nipocalimab. This trial focuses on pregnancies at risk for severe hemolytic disease of the fetus and newborn (HDFN). BillionToOne will supply its UNITY Fetal Antigen Non-invasive Prenatal Test (UNITY Fetal Antigen CTA) to screen and determine participant eligibility. HDFN is a rare condition resulting from blood type incompatibility between the pregnant individual and the fetus, which can lead to life-threatening anemia.

In November 2022, Myriad Genetics, Inc., a U.S.-based provider of genetic testing and precision medicine, acquired Gateway Genomics, LLC, a personal genomics and prenatal DNA company. The undisclosed acquisition is expected to enhance Myriad's women's health product portfolio and provide access to personalized genetic tests, strengthening its position in the market.

Major companies operating in the prenatal DNA sequencing market include Agilent Technologies Inc., BGI Group, F. Hoffmann-La Roche Ltd, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Myriad Genetics Inc., Invitae Corporation, PerkinElmer Inc., Macrogen Inc., Pacific Biosciences of California Inc., Genewiz LLC, 10x Genomics Inc., Oxford Nanopore Technologies Limited, Thermo Fisher Scientific Inc., Berry Genomics Co. Ltd., Centrillion Technology Holdings Corp., Cynvenio Biosystems Inc., Eurofins LifeCodexx AG, GeneDx Inc., Genoma SA, Helix OpCo LLC, Igenomix S.L., Integrated DNA Technologies Inc.

North America was the largest region in the prenatal DNA sequencing market in 2024. The regions covered in the prenatal dna sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal dna sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prenatal DNA sequencing market includes revenues earned by entities by provide services such as prenatal next-generation sequencing, whole genome sequencing, DNA extraction, DNA fragmentation, and data collection and sequence analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prenatal DNA Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal dna sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal dna sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The prenatal dna sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Genetic Diseases; Nonhereditary Diseases
2) By Application: Hemophilia; Down Syndrome; Cystic Fibrosis; Autism; DiGeorge Syndrome; AIDS (Acquired Immunodeficiency Syndrome); Cancer; Other Applications
3) By End User: Academic Research; Clinical Research; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
Subsegments:
1) By Genetic Diseases: Monogenic Disorders; Chromosomal Abnormalities
2) By Nonhereditary Diseases: Infectious Diseases; Maternal Health Conditions
Companies Mentioned: Agilent Technologies Inc.; BGI Group; F. Hoffmann-La Roche Ltd; Illumina Inc.; Laboratory Corporation of America Holdings; Natera Inc.; Myriad Genetics Inc.; Invitae Corporation; PerkinElmer Inc.; Macrogen Inc.; Pacific Biosciences of California Inc.; Genewiz LLC; 10x Genomics Inc.; Oxford Nanopore Technologies Limited; Thermo Fisher Scientific Inc.; Berry Genomics Co. Ltd.; Centrillion Technology Holdings Corp.; Cynvenio Biosystems Inc.; Eurofins LifeCodexx AG; GeneDx Inc.; Genoma SA; Helix OpCo LLC; Igenomix S.L.; Integrated DNA Technologies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Prenatal DNA Sequencing Market Characteristics

3. Prenatal DNA Sequencing Market Trends And Strategies

4. Prenatal DNA Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Prenatal DNA Sequencing Growth Analysis And Strategic Analysis Framework

5.1. Global Prenatal DNA Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Prenatal DNA Sequencing Market Growth Rate Analysis
5.4. Global Prenatal DNA Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Prenatal DNA Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Prenatal DNA Sequencing Total Addressable Market (TAM)

6. Prenatal DNA Sequencing Market Segmentation

6.1. Global Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Diseases
Nonhereditary Diseases
6.2. Global Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hemophilia
Down Syndrome
Cystic Fibrosis
Autism
DiGeorgre Syndrome
AIDS (Acquired Immunodeficiency Syndrome)
Cancer
Other Applications
6.3. Global Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Academic Research
Clinical Research
Hospitals And Clinics
Pharmaceutical And Biotechnology Companies
Other End Users
6.4. Global Prenatal DNA Sequencing Market, Sub-Segmentation Of Genetic Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monogenic Disorders
Chromosomal Abnormalities
6.5. Global Prenatal DNA Sequencing Market, Sub-Segmentation Of Nonhereditary Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Diseases
Maternal Health Conditions

7. Prenatal DNA Sequencing Market Regional And Country Analysis

7.1. Global Prenatal DNA Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Prenatal DNA Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prenatal DNA Sequencing Market

8.1. Asia-Pacific Prenatal DNA Sequencing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prenatal DNA Sequencing Market

9.1. China Prenatal DNA Sequencing Market Overview
9.2. China Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prenatal DNA Sequencing Market

10.1. India Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prenatal DNA Sequencing Market

11.1. Japan Prenatal DNA Sequencing Market Overview
11.2. Japan Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prenatal DNA Sequencing Market

12.1. Australia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prenatal DNA Sequencing Market

13.1. Indonesia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prenatal DNA Sequencing Market

14.1. South Korea Prenatal DNA Sequencing Market Overview
14.2. South Korea Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prenatal DNA Sequencing Market

15.1. Western Europe Prenatal DNA Sequencing Market Overview
15.2. Western Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prenatal DNA Sequencing Market

16.1. UK Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prenatal DNA Sequencing Market

17.1. Germany Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prenatal DNA Sequencing Market

18.1. France Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prenatal DNA Sequencing Market

19.1. Italy Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prenatal DNA Sequencing Market

20.1. Spain Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prenatal DNA Sequencing Market

21.1. Eastern Europe Prenatal DNA Sequencing Market Overview
21.2. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prenatal DNA Sequencing Market

22.1. Russia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prenatal DNA Sequencing Market

23.1. North America Prenatal DNA Sequencing Market Overview
23.2. North America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prenatal DNA Sequencing Market

24.1. USA Prenatal DNA Sequencing Market Overview
24.2. USA Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prenatal DNA Sequencing Market

25.1. Canada Prenatal DNA Sequencing Market Overview
25.2. Canada Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prenatal DNA Sequencing Market

26.1. South America Prenatal DNA Sequencing Market Overview
26.2. South America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prenatal DNA Sequencing Market

27.1. Brazil Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prenatal DNA Sequencing Market

28.1. Middle East Prenatal DNA Sequencing Market Overview
28.2. Middle East Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prenatal DNA Sequencing Market

29.1. Africa Prenatal DNA Sequencing Market Overview
29.2. Africa Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prenatal DNA Sequencing Market Competitive Landscape And Company Profiles

30.1. Prenatal DNA Sequencing Market Competitive Landscape
30.2. Prenatal DNA Sequencing Market Company Profiles
- 30.2.1. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. BGI Group Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

31. Prenatal DNA Sequencing Market Other Major And Innovative Companies

31.1. Natera Inc.
31.2. Myriad Genetics Inc.
31.3. Invitae Corporation
31.4. PerkinElmer Inc.
31.5. Macrogen Inc.
31.6. Pacific Biosciences of California Inc.
31.7. Genewiz LLC
31.8. 10x Genomics Inc.
31.9. Oxford Nanopore Technologies Limited
31.10. Thermo Fisher Scientific Inc.
31.11. Berry Genomics Co. Ltd.
31.12. Centrillion Technology Holdings Corp.
31.13. Cynvenio Biosystems Inc.
31.14. Eurofins LifeCodexx AG
31.15. GeneDx Inc.

32. Global Prenatal DNA Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prenatal DNA Sequencing Market

34. Recent Developments In The Prenatal DNA Sequencing Market

35. Prenatal DNA Sequencing Market High Potential Countries, Segments and Strategies

35.1 Prenatal DNA Sequencing Market In 2029 - Countries Offering Most New Opportunities
35.2 Prenatal DNA Sequencing Market In 2029 - Segments Offering Most New Opportunities
35.3 Prenatal DNA Sequencing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies